Evidence map›Paper›PMID 35725243›Full record

ArticleStroke and vascular neurology2022

Inhibition of the postsynaptic density protein 95 on the protective effect of Ang-(1-7)-Mas on cerebral ischaemia injury.

Bingrui Zhao, Zhe Wang, Xinyue Liang, Xiaoyan Wang, Kai Lin, Lihua Yuan, Jing Jiang, Cong Xu, Daolai Zhang, Yeying Sun and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stroke and vascular neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Bingrui Zhao *School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Zhe Wang *School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Xinyue Liang *School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Xiaoyan WangCollege of Intelligence and Information Engineering, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Kai LinSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Lihua YuanSuzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences, Suzhou, Jiangsu, China.
Jing JiangSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Cong XuSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Daolai ZhangSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Yeying SunSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China bian_1005@163.com sunyy@bzmc.edu.cn.
Weihua BianSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China bian_1005@163.com sunyy@bzmc.edu.cn.ORCID 0000-0003-2369-2073
Binzhou Medical University · CNChinese Academy of Sciences · CNShandong University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostsynaptic density protein-95 (PSD95) plays an important role in cerebral ischaemia injury, but its mechanism needs further research. This study aimed to explore the role of PSD95 in (Ang-(1-7))-Mas-mediated cerebral ischaemia protection and its regulatory mechanism.

methodsOxygen-glucose deprivation (OGD) neuron and rat middle cerebral artery occlusion (MCAO) models were used as in vitro and in vivo models, respectively. TAT-MAS9C was used to disrupt the interaction between PSD95 and Mas. The recombinant PSD95 adenovirus (Ad-PSD95) was used to overexpress PSD95 in neurons.

resultsResults showed that in OGD neurons, Ang-(1-7) could promote cell viability; reduce cell apoptosis; reduce the cell membrane localisation of Mas; upregulate the expression levels of pAKT, bcl-2 and I-κB; and downregulate the expression levels of Bax, pI-κB, tumour necrosis factor alpha and interleukin-1β. TAT-MAS9C could enhance the aforementioned effects of Ang-(1-7). However, the PSD95 overexpression inhibited the aforementioned effects of Ang-(1-7). In the MCAO rat model, the 2,3,5-triphenyltetrazolium chloride (TTC) staining showed that Ang-(1-7) reduced the infarct volume. The Morris water maze test showed that the number of crossings over the platform area in the Ang-(1-7) group was significantly increased. TAT-MAS9C could promote the protective effect of Ang-(1-7).

conclusionsResults suggested that PSD95 alleviated the activation of AKT and the inhibition of nuclear factor kappa B signalling pathway mediated by the Ang-(1-7)-Mas complex, thereby reducing neuronal activity, increasing apoptosis and inhibiting the Ang-(1-7)-Mas-mediated cerebral ischaemia protection.

Indexed as

Brain InjuriesBrain IschemiaAnimalsApoptosisDisks Large Homolog 4 ProteinInfarction, Middle Cerebral ArteryRatsSignal TransductionDisks Large Homolog 4 Proteinbraincerebral infarctionstroke

Identifiers

PMID35725243
PMCPMC9811564
OpenAlexW4283158344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.